Table 2.
Case # | HMB-45 | Melan-A | MiTF | Cathepsin K | Desmin | h-caldesmon | SMA | TFE3 | RAD51B |
---|---|---|---|---|---|---|---|---|---|
1 | 4+ H | 3+ S | 2+ H | 4+ S | 0 | 1+ | 0 | - | - |
2 | PPR | PPR | NP | NP | 0 | NP | PPR | NP | NP |
3 | 3+ S | 1+ S | 1+ W | 4+ S | 1+ S | 2+ H | 2+ S | - | - |
4 | 4+ S | 4+ H | 2+ W | 4+ S | 1+ W | 3+ H | PPR | - | - |
5 | 3+ H | PPR | NP | NP | NP | NP | 4+ S | - | - |
6 | 4+ S | 1+ W | 0 | 4+ S | 0 | 1+ S | 2+ S | - | - |
7 | 3+ S | 0 | 0 | 4+ S | 4+ S | 4+ S | 3+ S | Failed | Failed |
8 | 4+ S | 3+ H | 1+ W | 4+ S | 1+ S | 1+ W | 1+ H | - | - |
9 | 4+ S | 4+ S | 0 | 4+ S | 1+ H | 2+ S | 4+ S | - | - |
10 | 3+ S | 1+ W | 1+ W | 4+ S | 3+ H | 1+ S | 1+ S | - | - |
11 | 4+ S (Ep) 0 (Sp) |
4+ S (Ep) 0 (Sp) |
0 (Ep/Sp) | 4+ S (Ep) 0 (Sp) |
0 (Ep) 4+ (Sp) |
0 (Ep) 4+ (Sp) |
0 (Ep) 4+ (Sp) |
- | - |
12 | 2+ S | 1+ S | 2+ W | 4+ S | 2+ S | 0 | 0 | - | RAD51B-OPHN1 |
13 | 4+ S | 2+ H | 1+ W | 4+ H | 1+ S | 0 | NP | - | - |
14 | 4+ S | 0 | 0 | 4+ S | 0 | 0 | 4+ S | PSF-TFE3 | - |
15 | 4+ S | 3+ H | 4+ S | 4+ S | 3+ S | 0 | 2+ H | - | - |
16 | 4+ S | 0 | 1+ W | 4+ S | 4+ S | 0 | 4+ S | - | - |
17 | 4+ S | 0 | 1+ W | 4+ S | 2+ S | 0 | PPR | - | - |
18 | 4+ S | 1+ H | 3+ H | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
19 | 4+ S | 4+ H | 4+ W | 4+ S | 3+ S | 2+ S | 4+ H | - | - |
20 | 1+ H | 1+ S | 3+ W | 4+ S | 2+ S | 4+ S | 4+ S | - | - |
21 | 4+ S | 4+ S | 4+ S | 2+ W | 0 | 0 | 0 | - | - |
22 | 2+ S | 2+ S | 0 | 2+ H | 4+ S | 4+ S | 3+ S | - | - |
23 | 4+ S | 1+ S | 3+ W | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
24 | 2+ S | 1+ H | 4+ S | 3+ S | 4+ S | 4+ S | 4+ S | - | - |
25 | 4+ H | 0 | 4+ H | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
26 | 4+ S | 0 | 3+ H | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
27 | 4+ S | 0 | 0 | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
28 | 4+ S | 1+ W | 2+ W | 4+ H | 0 | 4+ S | 4+ S | - | - |
29 | 4+ H | 1+ W | 3+ H | 4+ S | 4+ S | 2+ S | 4+ S | - | - |
30 | 4+ S | 0 | 4+ S | 4+ S | 4+ S | 2+ S | 4+ S | - | - |
31 | 4+ S | 4+ S | 2+ H | 4+ S | 0 | 1+ H | 2+ S | - | - |
32 | 1+ S | 1+ S | 0 | 4+ S | 4+ S | 4+ S | 4+ S | - | - |
<1% (0), 1–5% (1+), 6–25% (2+), 26–50% (3+), >50% (4+), strong (S), heterogeneous (H), weak (W)
SMA=smooth muscle actin; PPR=positive per report; NP=not performed; Ep=epithelioid component; Sp=spindled component